General Information of This Metabolic Reaction (MR) (ID: MR002576)
Formula
CYP3A4 ...
SVG example
7-O-Demethylation
Reactant Cabazitaxel Product RPR112698
Reactant Info Product Info
Metabolic Enzyme Cytochrome P450 3A4 (CYP3A4) DME Info
Cytochrome P450 3A5 (CYP3A5) DME Info
Cytochrome P450 2C8 (CYP2C8) DME Info
Metabolic Type Oxidation - 7-O-Demethylation
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR002577 Cabazitaxel Cabazitaxel metabolite M1 Oxidation - Hydroxylation Cabazitaxel [1]
MR002575 Cabazitaxel RPR123142 Oxidation - 10-O-Demethylation Cabazitaxel [1]
MR002578 Cabazitaxel RPR130523 Unclear Cabazitaxel [1]
Other MR(s) Related to The Product of This MR
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR002567 RPR112698 Cabazitaxel metabolite M07 Oxidation - Hydroxylation Cabazitaxel [1]
MR002566 RPR112698 RP56976 Oxidation - 10-O-Demethylation Cabazitaxel [1]
References
1 A phase I open-label study investigating the disposition of [14C]-cabazitaxel in patients with advanced solid tumors Anticancer Drugs. 2015 Mar;26(3):350-8. doi: 10.1097/CAD.0000000000000185.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.